Press Resease

Pigmentation Disorders Treatment Market by Treatment (Chemical Peels, Microdermabrasion, Topical Drugs, Phototherapy, and Laser Therapy), by Key Disease Indications (Vitiligo, Melasma, Albinism, Solar Lentigines, and Post-inflammatory Hyperpigmentation), and by End Use (Dermatology Centers, Hospitals, and Aesthetic Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 29-Aug-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3304 Status : Published

Global pigmentation disorders treatment market expected to generate revenue of around USD 8,479.08 million by end of 2024, growing at a CAGR of around 7.02% between 2018 and 2024. The natural coloring of a human or animal's skin is known as pigmentation. Pigmentation is created due to the deposition of melanin, a pigment produced by melanocytes.

Description

The report covers forecast and analysis for the pigmentation disorders treatment market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pigmentation disorders treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pigmentation disorders treatment market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the pigmentation disorders treatment market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein treatment segment is benchmarked based on their market size, growth rate, and general attractiveness.

Global Pigmentation Disorders Treatment Market

The report provides company market share analysis in order to give a broader overview of the key players in the pigmentation disorders treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new treatment launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the pigmentation disorders treatment market on the global and regional basis. 

The study provides a decisive view of the pigmentation disorders treatment market by segmenting the market based on treatment, key disease indications, end use, and regions. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The treatment segment has been segmented into chemical peels, microdermabrasion, topical drugs, phototherapy, and laser therapy. Chemical peels segment holds the maximum share of the treatment segment owing to the rise in the development of genetically modified animals. Based on key disease indications, pigmentation disorders treatment market has been segmented into vitiligo, melasma, albinism, solar lentigines, and post-inflammatory hyperpigmentation. Based on end use, pigmentation disorders treatment market has been segmented dermatology centers, hospitals, and aesthetic clinics.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for pigmentation disorders treatment based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Allergan, Inc., Episciences, Inc., Bayer AG, La Roche-Posay, Pierre Fabre Laboratories, SkinCeuticals International, Obagi Medical Treatments Inc., and Alvogen, Inc. among others.

This report segments the global Pigmentation Disorders Treatment Market as follows:

Global Pigmentation Disorders Treatment Market: By Treatment

  • Chemical Peels
  • Microdermabrasion
  • Topical Drugs
  • Phototherapy
  • Laser Therapy

Global Pigmentation Disorders Treatment Market: By Key Disease Indications

  • Vitiligo
  • Melasma
  • Albinism
  • Solar Lentigines
  • Post-inflammatory Hyperpigmentation

Global Pigmentation Disorders Treatment Market: By End Use

  • Dermatology Centers
  • Hospitals
  • Aesthetic Clinics

Global Pigmentation Disorders Treatment Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Pigmentation Disorders Treatment market, 2017 - 2024 (USD Million)
    • 2.2. Global Pigmentation Disorders Treatment market : Snapshot
  •  
  • Chapter 3. Pigmentation Disorders Treatment- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Pigmentation Disorders Treatment market drivers: Impact analysis
      • 3.2.2. High demand for skin lightening treatments
      • 3.2.3. Increasing spending on lifestyle
    • 3.3. Market Restraints
      • 3.3.1. High costs related to cosmetic therapy
      • 3.3.2. Lack of awareness regarding skin disorders in developing regions
    • 3.4. Opportunities
      • 3.4.1. Rise in research and development activities
      • 3.4.2. Growth of medical tourism
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by treatment segment
      • 3.6.2. Market attractiveness analysis, by key disease indications segment
      • 3.6.3. Market attractiveness analysis, by end use segment
  •  
  • Chapter 4. Global Pigmentation Disorders Treatment Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Pigmentation Disorders Treatment market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Treatment Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Pigmentation Disorders Treatment Market - Treatment Segment Analysis
    • 5.1. Global Pigmentation Disorders Treatment market: Treatment overview
      • 5.1.1. Global Pigmentation Disorders Treatment market revenue share, by Treatment, 2017 and 2024
    • 5.2. Chemical Peels
      • 5.2.1. Global Pigmentation Disorders Treatment market for Chemical Peels, 2017 - 2024 (USD Million)
    • 5.3. Microdermabrasion
      • 5.3.1. Global Pigmentation Disorders Treatment market for Microdermabrasion, 2017 - 2024 (USD Million)
    • 5.4. Topical Drugs
      • 5.4.1. Global Pigmentation Disorders Treatment market for Topical Drugs, 2017 - 2024 (USD Million)
    • 5.5. Phototherapy
      • 5.5.1 Global Pigmentation Disorders Treatment market for Phototherapy, 2017 - 2024 (USD Million)
    • 5.6. Laser Therapy
      • 5.6.1. Global Pigmentation Disorders Treatment market for Laser Therapy, 2017 - 2024 (USD Million)
  •  
  • Chapter 6. Global Pigmentation Disorders Treatment Market - Key Disease Indications Segment Analysis
    • 6.1. Global Pigmentation Disorders Treatment market: Key Disease Indications overview
      • 6.1.1. Global Pigmentation Disorders Treatment market revenue share, by Key Disease Indications, 2017 and 2024
    • 6.2. Vitiligo
      • 6.2.1. Global Pigmentation Disorders Treatment market for Vitiligo, 2017 - 2024 (USD Million)
    • 6.3. Melasma
      • 6.3.1. Global Pigmentation Disorders Treatment market for Melasma, 2017 - 2024 (USD Million)
    • 6.4. Albinism
      • 6.4.1. Global Pigmentation Disorders Treatment market for Albinism, 2017 - 2024 (USD Million)
    • 6.5. Solar Lentigines
      • 6.5.1. Global Pigmentation Disorders Treatment market for Solar Lentigines, 2017 - 2024 (USD Million)
    • 6.6. Post-inflammatory Hyperpigmentation
      • 6.6.1 Global Pigmentation Disorders Treatment market for Post-inflammatory Hyperpigmentation, 2017 - 2024 (USD Million)
  •  
  • Chapter 7. Global Pigmentation Disorders Treatment Market - End Use Segment Analysis
    • 7.1. Global Pigmentation Disorders Treatment market: End-Use overview
      • 7.1.1. Global Pigmentation Disorders Treatment market revenue share, by End Use, 2017 and 2024
    • 7.2. Dermatology Centers
      • 7.2.1. Global Pigmentation Disorders Treatment market for Dermatology Centers, 2017 - 2024 (USD Million)
    • 7.3. Hospitals
      • 7.3.1. Global Pigmentation Disorders Treatment market for Hospitals, 2017 - 2024 (USD Million)
    • 7.4. Aesthetic Clinics
      • 7.4.1. Global Pigmentation Disorders Treatment market for Aesthetic Clinics, 2017 - 2024 (USD Million)
  •  
  • Chapter 8. Global Pigmentation Disorders Treatment Market - Regional Segment Analysis
    • 8.1. Global Pigmentation Disorders Treatment market: Regional overview
      • 8.1.1. Global Pigmentation Disorders Treatment market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
      • 8.2.2. North America Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
      • 8.2.3. North America Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.2.4.2. U.S. Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.2.4.3. U.S. Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.2.5.2. Canada Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.2.5.3. Canada Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.2.6.2. Rest of North America Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.2.6.3. Rest of North America Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
      • 8.3.2. Europe Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
      • 8.3.3. Europe Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.3.4.2. Germany Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.3.4.3. Germany Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.3.5.2. U.K. Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.3.5.3. U.K. Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.3.6.2. France Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.3.6.3. France Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.3.7.2. Italy Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.3.7.3. Italy Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.3.8.2. Spain Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.3.8.3. Spain Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.3.9. Russia
        • 8.3.9.1. Russia Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.3.9.2. Russia Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.3.9.3. Russia Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.3.10. Rest of Europe
        • 8.3.10.1. Rest of Europe Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.3.10.2. Rest of Europe Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.3.10.3. Rest of Europe Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
      • 8.4.2. Asia Pacific Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
      • 8.4.3. Asia Pacific Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.4.4.2. China Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.4.4.3. China Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.4.5.2. Japan Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.4.5.3. Japan Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.4.6.2. India Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.4.6.3. India Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.4.7. Australia
        • 8.4.7.1. Australia Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.4.7.2. Australia Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.4.7.3. Australia Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
      • 8.5.2. Latin America Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
      • 8.5.3. Latin America Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.5.4.2. Brazil Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.5.4.3. Brazil Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.5.5. Mexico
        • 8.5.5.1. Mexico Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.5.5.2. Mexico Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.5.5.3. Mexico Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.5.6. Argentina
        • 8.5.6.1. Argentina Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.5.6.2. Argentina Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.5.6.3. Argentina Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.5.7. Rest of Latin America
        • 8.5.7.1. Rest of Latin America Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.5.7.2. Rest of Latin America Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.5.7.3. Rest of Latin America Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
      • 8.6.2. Middle East and Africa Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
      • 8.6.3. Middle East and Africa Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.6.4. Saudi Arabia
        • 8.6.4.1. Saudi Arabia Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.6.4.2. Saudi Arabia Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.6.4.3. Saudi Arabia Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.6.5. UAE
        • 8.6.5.1. UAE Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.6.5.2. UAE Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.6.5.3. UAE Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.6.6.2. South Africa Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.6.6.3. South Africa Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.6.7. Qatar
        • 8.6.7.1. Qatar Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.6.7.2. Qatar Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.6.7.3. Qatar Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
      • 8.6.8. Rest of Middle East and Africa
        • 8.6.8.1. Rest of Middle East and Africa Pigmentation Disorders Treatment market revenue, by Treatment, 2017 - 2024 (USD Million)
        • 8.6.8.2. Rest of Middle East and Africa Pigmentation Disorders Treatment market revenue, by Key Disease Indications, 2017 - 2024 (USD Million)
        • 8.6.8.3. Rest of Middle East and Africa Pigmentation Disorders Treatment market revenue, by End Use, 2017 - 2024 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Allergan, Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Episciences, Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Bayer AG
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. La Roche-Posay
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Pierre Fabre Laboratories
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. SkinCeuticals International
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Obagi Medical Products Inc.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Alvogen, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments

Methodology

Free Analysis

The natural coloring of a human or animal's skin is known as pigmentation. Pigmentation is created due to the deposition of melanin, a pigment produced by melanocytes. Melanocytes are present below the epidermis. The oxidation of tyrosine, an amino acid, results in the production of melanin. Keratinocytes carry melanin to the skin surface. During skin pigmentation disorders, the color of the skin is affected. When melanocytes are damaged or become unhealthy the melanin production of the body is disturbed. This defect either darkens or lightens the skin. This abnormality of skin color can affect some skin patches or the whole body. Higher production of melanin results in darkening of the skin, whereas less production of melanin makes the skin lighter.

Hyperpigmentation refers to skin darkening caused by increased levels of melanin. Conditions that can cause hyperpigmentation include pregnancy, Addison's disease, and exposure to sunlight, among others. During hyperpigmentation, brown, red or pink spots or clusters appear on the skin surface. The affected skin areas appear dark compared to the rest of the skin. Spending time under the sun or acne breakout further aggravates hyperpigmentation. Some of the spots go away over a period of time; however, certain spots require intensive treatments. There are three main types of hyperpigmentation: sunspots, post-inflammatory hyperpigmentation, and melasma. Sunspots develop on areas of the skin exposed to intense sunlight like face, neck, and hands. Post-inflammatory hyperpigmentation is caused due to skin inflammation or injury. Melasma is caused as a result of hormonal changes.

Global Pigmentation Disorders Treatment Market

Hypopigmentation refers to the loss of skin color. Hypopigmentation is majorly caused due to genetic conditions, harsh environmental conditions, or injuries. Hypopigmentation is characterized by depletion of melanin, melanocytes, or amino acid tyrosine. It may be localized or can spread throughout the body. Multiple areas of the skin appear white in localized hypopigmentation. Some chronic skin disorders like Albinism, Vitiligo, Seborrheic dermatitis, Tinea versicolor, and Pityriasis Alba causes hypopigmentation. Hypopigmentation can be treated by using laser treatments or skin grafting.

As per the UN estimates, Albinism is present in 1 out of 17,000 to 20,000 people in North America and Europe. In Africa 1 in every 5,000 to 15,000 people have albinism. Around 80% of pregnant women in Mexico and 50-75% of pregnant women in the U.S. are affected by melasma. Prevalence of albinism is high in African nations. Approximately 1 in 5,000 to 15,000 people are estimated to be affected by albinism.

Factors such as high demand for skin lightening treatments, increasing spending on lifestyle, growing prevalence of skin disorders, and global warming will act as driving factors to the growth of global pigmentation disorders treatment market. Moreover, increasing adoption of smoking in young adults, high disposable income, and growing demand from millennials will boost the global pigmentation disorders treatment market. The rise in research and development activities and growth of medical tourism will act as an opportunity for the market players in the pigmentation disorders treatment market. However, high costs related to cosmetic therapy and lack of awareness regarding skin disorders in developing regions will restrict the growth of global pigmentation disorders treatment market.

The global pigmentation disorders treatment market has been segmented into treatment, key disease indications, end use, and region. The treatment segment has been segmented into chemical peels, microdermabrasion, topical drugs, phototherapy, and laser therapy. Chemical peels segment holds the maximum share of the treatment segment owing to a rise in disposable income. Based on key disease indications, pigmentation disorders treatment market has been segmented into vitiligo, melasma, albinism, solar lentigines, and post-inflammatory hyperpigmentation. Based on end use, pigmentation disorders treatment market has been segmented into dermatology centers, hospitals, and aesthetic clinics.

North America will be the dominant region during the forecast period. Heavy research and development activities and focus on lifestyle products will drive the market growth in this region. Europe will be the second largest market. The Asia Pacific is expected to grow at a rapid rate over the forecast period. Increase in medical tourism from North American and European countries will boost the pigmentation disorders treatment market in this region. Latin America market will grow at a conservative rate during the forecast period. The Middle East and Africa are expected to experience appreciable growth in the near future.

Some of the key players in the pigmentation disorders treatment market include Allergan, Inc., Episciences, Inc., Bayer AG, La Roche-Posay, Pierre Fabre Laboratories, SkinCeuticals International, Obagi Medical Products Inc., and Alvogen, Inc. among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com